# Exagen Inc. Reports Strong Q3 2025 Results
Canonical URL: https://biopharmsignal.com/news/XGN/exagen-inc-reports-strong-q3-2025-results
Ticker: XGN
Company: Exagen
Source: Exagen
Published: 2025-11-04 13:00 EST
Original Source URL: https://investors.exagen.com
## Summary

CARLSBAD, Calif. , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2025 , and recent corporate updates.     Three Months Ended September 30 ,   Nine Months Ended

## Article Body
CARLSBAD, Calif. , Nov. 04, 2025 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the quarter ended September 30, 2025 , and recent corporate updates.     Three Months Ended September 30 ,   Nine Months Ended
## Recent Company News
- 2026-06-01 13:00 EST — [Exagen Announces Publication of Systematic Review Confirming Robust Real-World Performance of AVISE Lupus](https://biopharmsignal.com/news/XGN/exagen-announces-publication-of-systematic-review-confirming-robust-real-world-performance-of-avise-lupus) — Source: Exagen
- 2026-05-11 12:00 EST — [Exagen Inc. Reports First Quarter 2026 Results](https://biopharmsignal.com/news/XGN/exagen-inc-reports-first-quarter-2026-results) — Source: Exagen
- 2026-04-27 13:00 EST — [Exagen Inc. to Announce First Quarter Financial Results on May 11, 2026](https://biopharmsignal.com/news/XGN/exagen-inc-to-announce-first-quarter-financial-results-on-may-11-2026) — Source: Exagen
- 2026-03-10 12:00 EST — [Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2025 Results](https://biopharmsignal.com/news/XGN/exagen-inc-reports-strong-fourth-quarter-and-full-year-2025-results) — Source: Exagen
- 2026-03-03 14:00 EST — [Exagen Inc. to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/XGN/exagen-inc-to-participate-in-upcoming-investor-conferences) — Source: Exagen
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)